Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals
Autor: | Reichard, John F., Maier, M. Andrew, Naumann, Bruce D., Pecquet, Alison M., Pfister, Thomas, Sandhu, Reena, Sargent, Edward V., Streeter, Anthony J., Weideman, Patricia A. |
---|---|
Zdroj: | In Regulatory Toxicology and Pharmacology 15 August 2016 79 Supplement 1:S67-S78 |
Databáze: | ScienceDirect |
Externí odkaz: |